Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ILMN · against 1,216 other Healthcare companies
Ranked #883 of 1,217 · scores higher than 27% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 20–29, including ILMN · Click a bar to see the companies
Mainly because of its earnings per share growth and 3-year revenue growth, which are weaker than most Healthcare peers.
| Metric | ILMN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 4.9% | 6.1% | 46% | 33% | |
| Earnings per share growthHigher is better · 682 reported | -33.3% | 9.7% | 16% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 0.2% | 5.8% | 29% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 883 | 11.1B CNY (≈$1.6B) | 27 | 61 | |
| 883 | 11.4B CNY (≈$1.6B) | 27 | 50 | |
| 883 | 3.1B CNY (≈$440M) | 27 | 59 | |
| 883 | 1.3B EUR (≈$1.4B) | 27 | 60 | |
| 883 | 36.0B USD | 27 | 46 | |
| 883 | 12.7B AUD (≈$8.4B) | 27 | 38 | |
| 883 | 3.2B EUR (≈$3.6B) | 27 | 61 | |
| 883 | 3.0B EUR (≈$3.3B) | 27 | 62 | |
| 895 | 7.9B CNY (≈$1.1B) | 26 | 64 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score